WEEKLY TOP 5
YOUR WEEKLY UPDATES FROM SHEBA MEDICAL CENTER
Gain valuable information about healthcare issues that affect you and your community
Chanukah: Sheba is A Light Unto the Nations
To put it mildly, the world is in turmoil. Wars, famine, natural disasters and health emergencies are sweeping the planet like never before. Sheba Global’s Israel Center for Disaster Medicine and Humanitarian Response team has been on constant call in 2022 to provide life-saving healthcare and medical assistance from Ukraine to Ethiopia and beyond, kindling hope without boundaries using the most advanced technologies.
Thousands of people from all walks of life, men, women, and children are being treated by our multi-talented medical professionals on an annual basis.
Already, various humanitarian response teams are being assembled for January missions to Nigeria, Ethiopia, Kenya and Ukraine. And no one knows where the call for urgent care will come from next.
But Sheba Medical Center and its Sheba Global international division stand ready to inject a ray of light into the darkness that is enveloping our planet.
We’d like to wish all of you
a festive Chanukah holiday,
filled with light and enjoyment!
SHEBA’S PROMISING IBD TREATMENT
NEW DRUGS BATTLING CANCER RECURRENCE
THE FUTURE OF HEALTH ANALYZED IN NEW ENGLAND JOURNAL OF MEDICINE
NEW TECH IN OPEN HEART SURGERY
FRIENDS OF ISRAEL CHAIRMAN JOINS GENERAL ATLANTIC
More Posts
Sheba Medical Center Join General Catalyst’s Health Assurance Ecosystem to Advance Innovative Medical Solutions
General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.
Revolutionizing Diagnostic Medicine: Sheba Partners with Aidoc for Early Intracerebral Hemorrhages Detection
A pioneer in the application of AI in clinical settings, Sheba has played a central role in the development of numerous solutions that are now used across the globe. This includes Aidoc, which was founded at Sheba and now provides advanced AI decision-support tools to many of the world’s leading medical centers.
Sheba and Vidac Pharma Partner to Overcome the Warburg Effect
CAR T-cell therapy is a revolutionary blood cancer treatment that involves extracting and genetically engineering a patient’s T-cells to produce chimeric antigen receptors, or CARs, that facilitate the targeting and elimination of malignant cells.
